The answer is yes, EQ is being produced by british dragon as we speak. If it is out on the market yet I don't know?
How do are they doing it? Well, in the case of boldenone we have a steroid that's inherently somewhat resistant to hepatic breakdown because of its 1,4-androstadiene base structure. Also known as dehydrotestosterone, boldenone can offer a "fair" level of oral bioavailability, probably in the same ballpark as Primobolan or Proviron. In this case BD has modified it with an acetate ester, a structure also found on Primobolan. This ester also helps protect the steroid, but not significantly.
Consumers can look at oral boldenone sort of like oral Primobolan or oral Trenbolone acetate. These steroids work if you take a high enough dosage, but also tend to be very cost ineffective compared to injecting the same agents. So in this case we're trading total oral bioavailability and potency for a safer (less liver toxic) oral option.
If you would like more info on the topic, check out the November issue of Muscular Developement, p.296